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Introduction: A Brief History of Animal Virology {#s0010}
------------------------------------------------

The history of human development has been shaped by at least three major recurring elements: (1) environmental changes; (2) human conflicts; (3) infectious diseases. With regard to infectious diseases, the impact has been not only directly on the human population, but also on the food supply. The origins of veterinary medicine are rooted in efforts to maintain the health of animals for food and fiber production, and animals essential for work-related activities. Control of animal disease outbreaks was not possible until the pioneering work of the late 19th century that linked microbes to specific diseases of plants and animals. Many attribute the beginning of virology with the work of Ivanofsky and Beijerinck (1892--1898) on the transmission of tobacco mosaic virus. Both scientists were able to show the transmission of the agent causing disease in tobacco plants using fluids that passed through filters that retained bacteria. Beijerinck also noted that the filterable agent could regain its "strength" from diluted material, but only if it were put back into the tobacco plants. The concept of a replicating entity rather than a chemical or toxin had its genesis with these astute observations. The era of veterinary virology had its beginning virtually at the same time as Beijerinck was characterizing tobacco mosaic virus transmission. Loeffler and Frosch (1898) applied the filtration criteria to a disease in cattle that later would be known as foot and mouth disease. Repeated passage of the filtrate into susceptible animals with the reproduction of acute disease firmly established the "contagious" nature of the filtrate and provided more evidence for a process that was inconsistent with toxic substances. These early studies provided the essential operational definition of viruses as filterable agents until chemical and physical studies revealed the structural basis of viruses nearly 40 years later.

In the early 20th century, use of the filtration criteria saw the association of many acute animal diseases with what were to be defined as viral infections: African horse sickness, fowl plague (high pathogenicity avian influenza), rabies, canine distemper, equine infectious anemia, rinderpest, and classical swine fever (hog cholera) ([Table 1.1](#t0010){ref-type="table"} ). In 1911, Rous discovered the first virus that could produce neoplasia (tumors), and for this discovery he was awarded a Nobel Prize. This early phase of virology was one of skepticism and uncertainty because of the limited tools available to define the filterable agents. Even with filtration, there were differences among the agents as to their size as defined by filter retention. Some agents were inactivated with organic solvents, whereas others were resistant. For equine infectious anemia, the acute and chronic forms of the disease were perplexing and an unresolved conundrum. These types of apparent inconsistencies made it difficult to establish a unifying concept for the filterable agents. For research on animal diseases, early workers were restricted to using animal inoculation in order to assess the impact of any treatment on any putative disease causing agent. For equine and bovine disease work, the logistics could be daunting. Help in providing definition to filterable agents came from the discovery of viruses that infected bacteria. Twort in 1915 detected the existence of a filterable agent that could kill bacteria. Like its plant and animal counterparts, the strength of a dilute solution of the bacterial virus could be regained by inoculating new cultures of bacteria. Felix d\'Herelle also noted the killing of bacteria by an agent that he called "bacteriophage." He defined the plaque assay for quantitating bacteriophage, a technique that became a keystone for defining the properties of viruses and for the studies that became the basis of virus genetics.Table 1.1Selected Moments in the History of VirologyYearInvestigator(s)Event1892IvanofskyIdentification of tobacco mosaic virus as filterable agent1898Loeffler, FroschFoot-and-mouth disease caused by filterable agent1898SanarelliMyxoma virus1900ReedYellow fever virus1900Mcfadyean, TheilerAfrican horse sickness virus1901Centanni, Lode, GruberFowl plague virus (avian influenza virus)1902Nicolle, Adil-BeyRinderpest virus1902Spruell, TheilerBluetongue virus1902AujeszkyPseudorabies virus1903Remlinger, Riffat-BayRabies virus1903DeSchweinitz, DorsetHog cholera virus (classical swine fever virus)1904Carré, ValléeEquine infectious anemia virus1905SpreullInsect transmission of bluetongue virus1905CarréCanine distemper virus1908Ellermann, BangAvian leukemia virus1909Landsteiner, PopperPoliovirus1911RousRous sarcoma virus---first tumor virus1915Twort, d\'HerelleBacterial viruses1917d\'HerelleDevelopment of the plaque assay1927DoyleNewcastle disease virus1928Verge, Christofornoni Seifried, KrembsFeline parvovirus (feline panleukopenia virus)1930GreenFox encephalitis (canine adenovirus 1)1931ShopeSwine influenza virus1931Woodruff, GoodpastureEmbryonated eggs for virus propagation1933Dimmock, EdwardsViral etiology for equine abortions1933Andrewes, Laidlaw, SmithFirst isolation of human influenza virus1933ShopeSwine natural host of pseudorabies1933Bushnell, BrandlyAvian bronchitis virus1935StanleyTobacco mosaic virus (TMV) crystallized; protein nature of viruses confirmed1938Kausche, Ankuch, RuskaFirst electron microscopy pictures---TMV1939Ellis, DelbruckOne step growth curve---bacteriophage1946Olafson, MacCallum, FoxBovine viral diarrhea virus1948Sanford, Earle, LikelyCulture of isolated mammalian cells1952Dulbecco, VogtPlaque assay for first animal virus---poliovirus1956Madin, York, McKercherIsolation of bovine herpesvirus 11957Isaacs, LindemannDiscovery of interferon1958Horne, BrennerDevelopment of negative-stain electron microscopy1961BeckerFirst isolation of avian influenza virus from wild bird reservoir1963Plummer, WatersonEquine abortion virus=herpesvirus1970Temin, BaltimoreDiscovery of reverse transcriptase1978Carmichael, Appel, ScottCanine parvovirus 21979World Health OrganizationWHO declares smallpox eradicated1981PedersenFeline coronavirus1981BaltimoreFirst infectious clone of an RNA virus1983Montagnier, Barre-Sinoussi, GalloDiscovery of human immunodeficiency virus1987PedersenFeline immunodeficiency virus1991Wensvoort, TerpstraIsolation of porcine reproductive and respiratory syndrome virus (PRRSV)1994MurrayHendra virus isolated1999West Nile virus enters North America2002SARS outbreak2005Palase, Garcia-Sastre, Tumpey, TaubenbergerReconstruction of the 1918 pandemic influenza virus2007End of vaccination program for rinderpest2011?Declaration of the eradication of rinderpest

The initial studies on tobacco mosaic virus led to further understanding of "filterable agents"---namely viruses. Specifically, the high concentration of virus produced in infected tobacco plants permitted the chemical and physical characterization of the infectious material. By the early 1930s, there was evidence that the agent infecting tobacco plants was composed of protein, and that antibodies produced in rabbits could neutralize the virus. The tobacco mosaic virus was crystallized in 1935, and in 1939 the first electron micrograph of a virus was recorded. The particulate nature of viruses was now an established fact. A further advance in animal virology was the use of embryonated eggs for culturing virus in 1931. In the same year, Shope identified influenza virus in swine; in 1933, influenza virus was isolated from human cases of the infection. The identification of the strain H1N1 in swine might be considered the first "emerging" disease in animals---that is, a virus crossing a species barrier and maintaining itself as an agent of disease in the new species. In an attempt to move away from large-animal experimentation, and to provide model systems for human diseases such as influenza, mice and rats became important tools for studying animal viruses. Thus we had the birth of laboratory animal medicine programs that have become the essential backbone of biomedical research.

The decade 1938--1948 saw major advances by Ellis, Delbruck and Luria in the use of bacteriophage to probe the mechanism of inheritance of phenotypic traits of these bacterial viruses. Advances in understanding the properties of viruses progressed much more rapidly with bacterial viruses, because the work could be done in artificial media, without any requirement for laborious and time-consuming propagation of viruses in either animals or plants. A key concept in virus replication, namely the latent period, was defined using one-step growth curve experiments with bacteriophage. This observation of the loss of infectivity for a period after the initiation of the infection directed research to define the mode of replication of viruses as totally distinct from that of all other replicating entities. Animal virus studies made a dramatic shift in emphasis with the development of reliable *in-vitro* animal cell cultures (1948--1955). As a result of intensive efforts to control poliovirus infections, single cell culture procedures were defined, cell culture media were standardized, a human cell line was developed, and growth of poliovirus in a non-neuronal cell demonstrated. These advances all permitted the development of a plaque assay for poliovirus 35 years after the concept was defined for bacteriophage. All the basic studies on animal viruses that were hindered by the necessity to work in animal systems were now possible, and the principles established for bacteriophage could be explored for animal viruses. The cell culture era of animal virology had begun.

The advances in virology driven by human disease control efforts were directly applicable to animal virology. Bovine viral diarrhea virus was identified as a new disease-causing agent in cattle in 1946 and by the late 1950s was considered the most economically important disease of cattle in the United States. Cell culture procedures permitted isolation of the virus and the production of a vaccine by the early 1960s. Influenza virus was detected for the first time in wild birds in 1961, which led to the identification of water fowl and shore birds as the natural reservoir of influenza A viruses. An apparent cross-species incursion of a feline parvovirus variant produced the worldwide epizootic of canine parvovirus in the late 1970s. Again, standard *in-vitro* cell culture procedures identified the new agent and soon enabled the production of an effective vaccine. The entire arterivirus family (*Arteriviridae*) was identified in the cell culture era of virology---specifically, equine arteritis virus (1953), lactate dehydrogenase-elevating virus (1960), simian hemorrhagic fever virus (1964), and porcine reproductive and respiratory syndrome virus (1991). The discovery of human immunodeficiency virus (HIV) in 1983 attracted global attention, but the identification of simian immunodeficiency virus shortly thereafter may ultimately be of equal importance to the eventual control of human HIV infection. The primate system provided the animal models for studies of pathogenesis and vaccine development, and the existence of the simian virus in Old World primates provided the link to the origin of HIV as a cross-species (species jumper) infection.

The beginnings of the molecular era of virology reside in the late 1970s and early 1980s. Although not related to virology, the development of the polymerase chain reaction (PCR) in 1983 was to have an impact on virology as has no other technique to date. Cloning of nucleic acid sequences led to the first infectious molecular clone of a virus (poliovirus) in 1981. The impact of molecular techniques on virus detection and diagnostics was demonstrated with the identification of hepatitis C virus by molecular means without isolation (*in-vitro* culture of the virus). Viruses that could not be easily cultured *in vitro*---such as papillomaviruses, noroviruses, rotaviruses, and certain nidoviruses---could now be characterized and routinely detected by tests at the molecular level. A remarkably impressive feat spear-headed by Jeffrey Taubenberger was the molecular reconstruction of an infectious virus from RNA fragments representing the pandemic 1918 influenza A virus. Dreams of recreating extinct animals by molecular techniques may be farfetched, but the possibility exists for determining the early precursors of currently circulating viruses. Rapid and inexpensive nucleotide sequencing strategies are again redefining virology, and whole genomic sequencing is likely to replace less exact procedures for identifying and characterizing virus isolates. Metagenomic analyses of water and soil samples have identified myriads of new viruses, leaving some to estimate that viruses may contain more genetic information than all other species on earth combined.

In the early periods of virology, the discipline was dependent upon advances in the chemical and physical sciences. Defining the characteristics of the "filterable agents" was not possible by simply observing the impact of the agent on its host. However, as time went on, viruses became tools with which to probe the basic biochemical processes of cells, including gene transcription and translation. The bacterial viruses assisted in defining some of the basic principles of genetics through the study of mutations and the inheritance of phenotypic changes. As analytical chemical procedures developed, it was shown that viruses contained nucleic acids, and when Watson and Crick defined the structure of DNA, viruses became key players in defining the role of nucleic acids as the database for life. Progress was so rapid in the field of virology that, by the 1980s, some believed that the future value of viruses would simply be as tools for studying cellular processes. However, the unpredictable emergence of new viruses such as HIV, hepatitis C, Nipah and Hendra, and high-pathogenic H5N1 influenza, together with the expansion of individual viruses into previously free areas such as West Nile virus into North America and bluetongue virus into Europe, clearly confirm that much has yet to be learned about this class of infectious agents and the diseases that they cause.

Veterinary virology began as a discipline focusing on the effects of viral infections on animals of agricultural significance. Control of these infections relied on advances in understanding the disease process, in the characterization of the viruses, in the development of the fields of immunology and diagnostic technologies, and in the establishment of regulations controlling the movement of production animals. Initial experiences confirmed that eradication of some infectious diseases from defined areas could be achieved with a test and slaughter program, even in the absence of an effective vaccine. For example, the apparent recent global eradication of rinderpest was achieved through slaughter of infected animals, restriction of animal movement from enzootic areas to areas free of the infection, and vaccination of animals in enzootic areas. In this type of control program, the individual animal could be sacrificed for the good of the production unit. With the increase in the importance of companion animals in today\'s society, control programs based on depopulation of infected animals cannot be utilized simply because the individual animal is the important unit as in human medicine. Thus canine parvovirus infections cannot be controlled by killing the affected animals and restricting the movement of dogs, and effective vaccines must continue to be developed and utilized in a science-based immunization program. Diagnostic tests must be deployed that can rapidly detect infectious agents in a time frame such that the test results can direct treatment. As we become more aware of the interaction between domestic animals and wildlife, we also must face the reality that there are viruses transmitted by insect vectors that do not respect national boundaries and for which the range may be expanding because of climatic changes. Enhanced surveillance programs, novel control strategies, and antiviral drugs will need to be developed continually in the future, particularly for those diseases in which vaccination is not cost-effective.

Viruses have traditionally been viewed in a rather negative context---disease-producing agents that must be controlled or eliminated. However, viruses have some beneficial properties that can be exploited for useful purposes. Specifically, viruses have been engineered to express proteins for production of non-viral proteins (baculovirus) or to express viral proteins for immunization purposes (e.g., poxvirus and adenovirus vectored vaccines). Lentiviruses have been modified for the purpose of inserting new genetic information into cells for research purposes and for possible use in gene therapy, as have a wide variety of other viruses, including adeno-associated viruses (parvoviruses). Bacteriophages are being considered in the context of controlling certain bacterial infections, and viruses have the hypothetical potential to be vectors that selectively target tumor cells for controlling cancers. In the broader context of the Earth\'s ecosystems, viruses are now viewed in a more positive sense, in that they may be a component of population control and perhaps a force in the evolution of species. Although restricting the population of agriculturally important animals is viewed as a negative from the human perspective, the ecosystem might benefit from the reduction of one species if its success is at the expense of others. We are happy to see an insect infestation curtailed by baculoviruses, but less pleased to see the loss of poultry by influenza virus, even though the two events may be ecologically equivalent. We are now fully comfortable with the concept of beneficial bacteria in the ecosystem of the human body. Do we need to start to consider that viruses that have evolved with the species may also have beneficial properties?

Characteristics of Viruses {#s0015}
--------------------------

Following the initial operational definition of a virus as a filterable agent, attempts were made to identify properties of viruses that made them distinct from other microorganisms. Even from the earliest times, it was evident that the filterable agents could not be cultivated on artificial media, and this particular characteristic has withstood the test of time, in that all viruses are obligate intracellular parasites. However, all obligate intracellular parasites are not viruses ([Table 1.2](#t0015){ref-type="table"} ). Members of certain bacterial genera also are unable to replicate outside a host cell (*Ehrlichia*, *Anaplasma*, *Legionella*, *Rickettsia*, are examples). These "degenerate" bacteria lack key metabolic pathways, the products of which must be provided by the host cell. Viruses, by contrast, lack all metabolic capabilities necessary to reproduce, including energy production and the processes necessary for protein synthesis. Viruses do not possess standard cellular organelles such as mitochondria, chloroplasts, Golgi, and endoplasmic reticulum with associated ribosomes. However, cyanophages do encode proteins involved in photosynthesis that are viewed as increasing viral fitness by supplementing the host cell systems. Similarly, certain bacteriophages have genomes that encode enzymes involved in the nucleotide biosynthetic pathway. Outside the living cell, viruses are inert particles whereas, inside the cell, the virus utilizes the host cell pro-cesses to produce its proteins and nucleic acid for the next generation of virus. As will be noted later, the protein-coding capacity of viruses ranges from just a few proteins to nearly 1000. This range of complexity mirrors the diverse effects viral infections have on host cell metabolism, but the outcome of an infection is the same---the production of more progeny viruses.Table 1.2Properties of Unicellular Microorganisms and VirusesPropertyBacteriaRickettsiaeMycoplasmasChlamydiaeViruses\>300 nm diameter[a](#tbl2fna){ref-type="table-fn"}++++−Growth on non-living medium+−+−−Binary fission++++−DNA and RNA[b](#tbl2fnb){ref-type="table-fn"}++++−Functional ribosomes++++−Metabolism++++−[^1][^2]

A second inviolate property of viruses is that they do not reproduce by binary fission, a method of asexual reproduction in which a pre-existing cell splits into two identical daughter cells; in the absence of limiting substrate, the population of cells will double with each replication cycle, and at all points in the replication cycle there exists a structure that is identifiable as an intact cell. For viruses, the process of reproduction resembles an assembly line in which various parts of the virus come together from different parts of the host cell to form new virus particles. Shortly after the virus attaches to a host cell, it enters the cell and the intact virus particle ceases to exist. The viral genome then directs the production of new viral macromolecules, which results ultimately in the re-emergence of intact progeny virus particles. The period of time between the penetration of the virus particle into the host cell and the production of the first new virus particle is designated as the *eclipse period*, and the duration of this period varies with each virus family. Disrupting cells during the eclipse period will not release significant numbers of infectious virus particles. Uninterrupted, a single infectious particle can replicate within a single susceptible cell to produce thousands of progeny virus particles.

As more sensitive analytical techniques became available and more viruses were identified, some of the criteria that defined a virus became less absolute. In general, viruses contain only one type of nucleic acid that carries the information for replicating the virus. However, is it now clear that some viruses do contain nucleic acid molecules other than the genomic DNA or RNA. For retroviruses, cellular transfer (t)RNAs are essential for the reverse transcriptase reaction, and studies have shown that 50--100 tRNA molecules are present in each mature virion. Similarly in herpesviruses, data show that host cell and viral transcripts localize to the tegument region of the mature virion. Early studies defined viruses by their tiny size; however, viruses now have been identified that are physically larger than some mycoplasma, rickettsia, and chlamydia. The newly discovered mimivirus group is an exception to existing rules: the virion is approximately 750 nm in diameter, with a DNA genome of 1.2 mbp. Because of the size of the virion, it would be retained by standard 300-nm filters traditionally used for separating bacteria from viruses. The genomic size is similar to that of the rickettsia and chlamydia, and more than 900 protein-encoding genes have been identified, at least 130 having been identified in mimivirus virions. Most surprising was the finding that the virus encodes genes involved in protein synthesis, such as aminoacyl-tRNA synthetases. The discovery of mimiviruses has revived the debate as to the origin of viruses, but sequence data indicate that this family of viruses is linked to the nucleocytoplasmic large DNA viruses, specifically viruses in the families *Poxviridae* and *Iridoviridae.*

### Chemical Composition of the Virion {#s0020}

The chemical composition of virus particles varies markedly between those of individual virus families. For the simplest of viruses such as parvoviruses, the virion is composed of viral structural proteins and DNA; in the case of enteroviruses it comprises viral proteins and RNA. The situation becomes more complex with the enveloped viruses such as herpesviruses and pneumoviruses. These types of virus mature by budding through different cellular membranes that are modified by the insertion of viral proteins. For the most part, host-cell proteins are not a significant component of viruses, but minor amounts of cellular proteins can be identified in viral membranes and in the interior of the virus particle. Host-cell RNA such as ribosomal RNA can be found in virions, but there is no evidence for a functional role in virus replication. For enveloped viruses, glycoproteins are the major type of protein present on the exterior of the membrane. The existence/presence of a lipid envelope provides an operational method with which to separate viruses into two distinct classes---those that are inactivated by organic solvents (enveloped) and those that are resistant (non-enveloped).

### Viral Nucleic Acids in the Virion {#s0025}

Viruses exhibit a remarkable variety of strategies for the expression of their genes and for the replication of their genome. If one considers the simplicity of RNA plant viroids (247--401 nt) at one extreme and the mimiviruses (1.2 mbp) at the other, one might conclude that viruses have perhaps exploited all possible means of nucleic acid replication for an entity at the subcellular level. The type of nucleic acid and the genomic structure of the nucleic acids are used to classify viruses. As viruses contain only one nucleic acid type with respect to transmitting genetic information, the virus world can simply be divided into RNA viruses and DNA viruses ([Table 1.3](#t0020){ref-type="table"} ). For RNA viruses, one major distinction is whether the virion RNA is of *positive sense* or polarity, directly capable of translation to protein, or of *negative sense* or polarity, which requires transcription of the genome to generate mRNA equivalents. Within the negative-strand group, there are single-strand whole-genome viruses (e.g., *Paramyxoviridae*) and segmented genome viruses (e.g., *Orthomyxoviridae*---six, seven, or eight segments; *Bunyaviridae*---three segments; *Arenaviridae*---two segments). The *Retroviridae* are considered diploid, in that the virion contains two whole-genomic positive-sense RNAs. Another unique configuration is the viruses with double-stranded RNA genomes. The *Birnaviridae* have two segments and the *Reoviridae* have 10, 11, or 12 segments, depending on the genus of virus. The size of animal RNA viral genomes ranges from less than 2 kb (*Deltavirus*) to more than 30 kb for the largest RNA viruses (*Coronaviridae*). Table 1.3Viral Properties that Distinguish and Define Virus FamiliesFamilyNature of the GenomePresence of an EnvelopeMorphologyGenome ConfigurationGenome Size (kb or kbp)Virion Size \[diameter (nM)\]*Poxviridae*dsDNA+pleomorphic1 linear130--375250×200×200*Iridoviridae*dsDNA+/−isometric1 linear135--303130--300*Asfarviridae*dsDNA+spherical1 linear170--190173--215*Herpesviridae*dsDNA+isometric1 linear125--240150*Adenoviridae*dsDNA−isometric1 linear26--4580--100*Polyomaviridae*dsDNA−isometric1 circular540--45*Papillomaviridae*dsDNA−isometric1 circular7--855*Hepadnaviridae*dsDNA-RT+spherical1 linear3--442--50*Circoviridae*ssDNA−isometric1 -- or +/−circular212--27*Parvoviridae*ssDNA−isometric1 +/− linear4--618--26*Retroviridae*ssRNA-RT+spherical1+(dimer)7--1380--100*Reoviridae*dsRNA−isometric10--12 segments19--3260--80*Birnaviridae*dsRNA−isometric2 segments5--660*Paramyxoviridae*NssRNA+pleomorphic1−segment13--18\~150*Rhabdoviridae*NssRNA+bullet-shaped1−segment11--15100--430×45--100*Filoviridae*NssRNA+filamentous1−segment≈19600--800×80 in diameter*Bornaviridae*NssRNA+spherical1−segment980--100*Orthomyxoviridae*NssRNA+pleomorphic6--8−segments10--1580--120*Bunyaviridae*NssRNA+spherical3−or +/− segments11--1980--120*Arenaviridae*NssRNA+spherical2 +/− segments1150--300*Coronaviridae*ssRNA+spherical1+segment38--31120--160*Arteriviridae*ssRNA+spherical1+segment13--1645--60*Picornaviridae*ssRNA−isometric1+segment7--9≈30*Caliciviridae*ssRNA−isometric1+segment7--827--40*Astroviridae*ssRNA−isometric1+segment6--728--30*Togaviridae*ssRNA+spherical1+segment10--12≈70*Flaviviridae*ssRNA+spherical1+segment10--1240--60*Hepevirus* (unassigned)ssRNA−isometric1+segment727--34*Anellovirus* (unassigned)ssDNA−isometric1−circular3--430--32[^3]

For the animal DNA viruses, the overall structure of the genomes is less complex, with either a single molecule of single-stranded (ss)DNA or a single molecule of double-stranded (ds)DNA. For the dsDNA viruses, the complexity ranges from the relatively simple circular super-coiled genome of the *Polyomaviridae* and *Papillomaviridae* (5--8 kbp) to the linear *Herpesvirinae* (125--235 kbp) with variable sequence rearrangements, which for the *Simplexvirus* can result in four isomeric forms. The ssDNA viral genomes are either linear (*Parvoviridae*) or circular (*Circoviridae* and *Anellovirus*), with sizes ranging from 2.8 to 5 kbp.

The size of the genome certainly reflects on the protein coding capacity of the virus, but in all cases there is not a simple calculation that reliably estimates this relationship. Parts of the viral genome are typically regulatory elements necessary for the translation of the proteins, replication of the genome, and transcription of viral genes (promoters, termination signals, polyadenylation sites, RNA splice sites, etc.). For synthesis of proteins, viruses have used a number of strategies to increase the relative coding capacity of the genome. For example, the *P* gene in Sendai virus (*Respirovirus*) directs the synthesis of at least seven viral proteins by several different mechanisms. One mechanism involves "RNA editing" whereby the RNA polymerase inserts G residues at specific sites in the growing mRNA molecule. This results in a series of proteins with the same amino terminus but with different ending points (different carboxyl termini). A different series of proteins are generated by using alternative start codons, which results in a series of proteins with different amino termini, but the same carboxyl terminus. For viruses such as the *Retroviridae*, RNA splicing is used to generate proteins that otherwise would not be produced using the linear coding capacity of the genome. Although the feature is not directly related to coding capacity, viruses also use the same protein for several functions. As an example, the NS3 protein of the member viruses of the family *Flaviviridae* is a multifunctional protein that has at its amino terminal region a serine protease activity and at its carboxyl terminal significant homology to supergroup 2 RNA helicases. One could easily envision that these two functions were on separate proteins that became fused to enhance functionality or to reduce the coding capacity of the genome.

### Viral Proteins in the Virion {#s0030}

The genomes of animal viruses encode from as few as one protein to more than 100. Those that are present in virions (mature virus particles) are referred to as *structural* proteins whereas those involved in the assembly of the particle, replication of the genome, or modification of the host innate response to infection, are referred to as *non-structural* proteins. There is some ambiguity for enzymes that are essential for the initial stages of virus replication, such as the RNA polymerases for the negative-strand RNA viruses (*Paramyxoviridae*, *Rhabdoviridae*, etc.). As the first step in the replication cycle once the nucleocapsid enters the cytoplasm is transcription of the viral genome, the polymerase must be part of the mature virion. Whether the polymerase has a structural role in the mature particle in addition to its transcription activity remains unresolved. Numerous other viral proteins that occur within the virions of complex viruses (*Poxviridae*, *Herpesviridae*, *Asfarviridae*) have no apparent structural role.

Virion proteins fall into two general classes: modified proteins and unmodified proteins. The capsids of the non-enveloped viruses are composed of proteins with few modifications, as their direct amino acid interactions are essential for the assembly of the protein shells. Proteolytic cleavage of precursor proteins in the nascent capsid is not uncommon in the final steps of assembly of the mature capsid proteins. Glycoproteins are predominantly found in those viruses that contain a viral membrane. These structural proteins can be either a type I integral membrane protein (amino terminus exterior) (e.g., hemagglutinin \[HA\] of influenza virus) or type II (carboxyl terminus exterior) (e.g., neuraminidase (NA) of influenza virus). Glycosylation patterns may differ even amongst viruses that mature in the same cells, because *N*- and *O*-linked glycosylation sites on the virion proteins vary among the virus families. The glycoproteins involved in virion assembly have a cytoplasmic tail that communicates with viral proteins on the inner surface of the membrane to initiate the maturation process for production of the infectious virus particle. Structural proteins in the infectious virus particle have a number of key functions: (1) to protect the genomic nucleic acid and associated enzymes from inactivation; (2) to provide receptor-binding sites for initiation of infection; (3) to initiate or facilitate the penetration of the viral genome into the correct compartment of the cell for replication.

### Viral Membrane Lipids {#s0035}

For viruses that mature by budding through a cellular membrane, a major constituent of the virion is phospholipid that forms the structural basis of the viral membrane. The maturation site for viruses can be the plasma membrane, nuclear membrane, Golgi, or the endoplasmic reticulum. For those viruses budding from the plasma membrane, cholesterol is a constituent of the viral membrane, whereas the envelopes of those viruses that bud from internal membranes lack cholesterol. The budding process is not random, in that specific viral glycoprotein sequences direct developing particles to the proper location within the inner membrane surface. In polarized cells---cells with tight junctions, giving the cell a defined apical and basal surface---virus budding will be targeted to one surface over the other. For example, in Madin--Darby canine kidney (MDCK) cells, influenza virus will bud on the apical surface, whereas vesicular stomatitis virus buds from the basal surface. The transmembrane domain of viral glycoproteins targets specific regions of the cellular membrane for budding. For influenza virus, budding is associated with "lipid rafts," which are microdomains of the plasma membrane rich in sphingolipids and cholesterol.

Viral Morphology {#s0040}
----------------

Early attempts to characterize viruses were hampered by the lack of appropriate technology. Filtration and sensitivity to chemical agents were two standard tests that were applied to new disease agents for nearly 40 years. Work with tobacco mosaic virus in the 1930s strongly suggested that the virus was composed of repeating protein subunits, and crystallization of the virus in 1935 supported this notion. However, it was not until 1939 that a virus was visualized using an electron microscope. Tobacco mosaic virus appeared as a rod-shaped particle, confirming the particulate nature of viruses. A major advance in determining virus morphology was the development of negative-stain electron microscopy in 1958. In this procedure, electron-dense stains were used to coat virus particles and produce a negative image of the virus with enhanced resolution ([Figure 1.1](#f0010){ref-type="fig"} ). [Figure 1.2](#f0015){ref-type="fig"} depicts the spectrum of morphological types represented by animal viruses. As indicated earlier, the size of virion ranges from 750 nm down to 20 nm. With this range, it is not surprising that there were inconsistencies noted in filtration studies.Figure 1.1(A) Model of particle of Tobacco mosaic virus (TMV). Also shown is the RNA as it is believed to participate in the assembly process. (B) Negative-contrast electron micrograph of TMV particle stained with uranyl acetate. The bar represents 100 nm.\[From *Virus Taxonomy: Eighth Report of the International Committee on Taxonomy of Viruses* (C. M. Fauquet, M. A. Mayo, J. Maniloff, U. Desselberger, L. A. Ball, eds), p. 1009. Copyright © Elsevier (2005), with permission.\]Figure 1.2Diagrammatic representation of the spectrum of morphological types represented by animal viruses.\[From *Virus Taxonomy: Eighth Report of the International Committee on Taxonomy of Viruses* (C. M. Fauquet, M. A. Mayo, J. Maniloff, U. Desselberger, L. A. Ball, eds), p. 14. Copyright © Elsevier (2005), with permission.\]

Advances in determining virus morphology down to the atomic level came from studies initially using X-ray crystallography and then combining this technique with other structural techniques such as electron cryomicroscopy (cryo-EM). In this process, samples are snap frozen and examined at temperatures of liquid nitrogen or liquid helium ([Figure 1.3](#f0020){ref-type="fig"} ). Cryo-EM offered the advantage that the samples are not damaged or distorted in the process of analyzing the structure, as occurs with negative-stain electron microscopy and X-ray crystallography. However, the individual images generated by this process are not as defined as those obtained with crystallography. Critical to these analyses were the developments in computer hardware and software that were able to capture, analyze, and construct the three-dimensional images from literally thousands of determinations. This "averaging" process can only work if the virus particles are uniformly the same size and shape. For many viruses, this uniformity is met by having the symmetry of a type of polyhedron known as an icosahedron. For intact virus particles showing icosahedral symmetry, the physical location of the individual peptides could be identified and the areas of the folded peptides that are on the surface of the virion were mapped. These areas could be linked to the specific epitopes recognized by monoclonal antibodies. In other studies, the binding site on the virion for the cellular receptor was mapped, which opened the possibility of developing antiviral drugs targeting these defined areas. X-ray crystallography can also be used to analyze subunits of a virus, such as was done for the HA protein of influenza virus ([Figure 1.4](#f0025){ref-type="fig"} ). The impact of mutations in the HA peptide as they related to changes in the binding of antibodies or host-cell receptors could be determined with these advanced technologies.Figure 1.3(A) Cryo-image reconstruction of recombinant Norwalk virus (NV)-like particles (rNV VLPs). (B) Cryo-image reconstruction of Primate calicivirus. A set of icosahedral five- and threefold axes is marked. (C) Central cross-section of rNV VLPs. (D) Electronic rendering of Norwalk virus. (E) Diagrammatic representation of a T=3 icosahedral structure. (F) Negative-stain electron micrograph of bovine calicivirus particles. The bar represents 100 nm.\[From *Virus Taxonomy: Eighth Report of the International Committee on Taxonomy of Viruses* (C. M. Fauquet, M. A. Mayo, J. Maniloff, U. Desselberger, L. A. Ball, eds), p. 843. Copyright © Elsevier (2005), with permission.\]Figure 1.4Crystal structure of the HA protein of influenza virus 1918 virus and comparison with other human, avian, and swine HAs. (A) Overview of the 18HA0 trimer, represented as a ribbon diagram. Each monomer is colored differently. (B) Structural comparison of the 18HA0 monomer (red) with human H3 (green), avian H5 (orange), and swine H9 (blue) HA0s.\[From J. Stevens, A. L. Corper, C. F. Basler, J. K. Taubenberger, P. Palese, I. A. Wilson. Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. *Science***303**, 1866--1870 (2004), with permission.\]

### Virion Structure {#s0045}

The *virion*---that is, the complete virus particle---of a simple virus consists of a single molecule of nucleic acid (DNA or RNA) surrounded by a morphologically distinct capsid composed of viral protein subunits (virus encoded polypeptides). The protein subunits can self-assemble into multimer units (structural units), which may contain one or several polypeptide chains. Structures without the nucleic acid can be detected and are referred to as empty capsids. The meaning of the term *nucleocapsid* can be somewhat ambiguous. In a strict sense, a capsid with its nucleic acid is a nucleocapsid, but for simple viruses such as poliovirus, this structure is also the virion. For flaviviruses, the nucleocapsid (capsid+RNA) is enclosed in a lipid envelope and the nucleocapsid does not represent the complete virion. For paramyxoviruses, the nucleocapsid refers to a structure composed of a single strand of RNA complexed to a viral protein that assembles in the form of an α helix. The nucleocapsid assembles into a complete virion by obtaining a lipid envelope from host cell membranes modified by the insertion of viral proteins.

### Virion Symmetry {#s0050}

For reasons of evolutionary progression and genetic economy, virions are assembled from several copies of a few kinds of protein subunit. The repeated occurrence of similar protein--protein interfaces leads to assembly of the subunits into symmetrical nucleocapsids. This efficiency of design also depends on the principles of *self-assembly*, wherein structural units are brought into position through random thermal movement and are bonded in place through weak chemical bonds. Although it is possible to express viral proteins in bacteria such as *Escherichia coli* and have capsids self-assemble (simian virus 40 and hepatitis B, for example), it is now recognized that most viruses have some help in the virion assembly process. This help can come from the interaction of the viral proteins with the viral genome, with cellular membranes, or with cellular chaperone proteins. This "help" may be simply concentrating the viral proteins to enhance chances of interactions, providing an organization matrix, or inducing a conformational change needed to enhance binding. For large viruses (*Herpesvirinae* and *Adenoviridae*, for example) with icosahedral nucleocapsids, non-structural viral proteins referred to as scaffolding proteins take an active part in the assembly of the capsid, but are not present in the completed virion.

Viruses come in a variety of shapes and sizes that depend on the shape, size, and number of their protein subunits and the nature of the interfaces between these subunits ([Figure 1.2](#f0015){ref-type="fig"}). However, only two kinds of symmetry have been recognized in virus particles: icosahedral and helical. The symmetry found in isometric viruses is invariably that of an icosahedron; virions with icosahedron symmetry have 12 vertices (corners), 30 edges, and 20 faces, with each face an equilateral triangle. Icosahedra have two-, three-, and fivefold rotational symmetry, with the axes passing through their edges, faces, and vertices, respectively ([Figure 1.5](#f0030){ref-type="fig"} ). The icosahedron is the optimum solution to the problem of constructing, from repeating subunits, a strong structure enclosing a maximum volume. Parvoviruses represent one of the simplest capsid designs, being composed of 60 copies of the same protein subunit---three subunits per face of the icosahedron. The protein is folded into a structure referred to as a "jelly-roll β-barrel" that forms a block-like profile with an arm-like extension that provides the contact point with other subunits for stabilizing the protein--protein interactions. In the simplest arrangement, the size of the protein subunit determines the volume of the capsid. With a single capsid protein of 60 copies, only a small genome can be accommodated within the capsid (canine parvovirus=5.3 kb ssDNA). Viruses with larger genomes have solved the problem of limited capsid volume, but the basic structure of the capsid remains the icosahedron. The explanations for the ways viruses maintain the icosahedron symmetry with repeating structural units is beyond the scope of this text.Figure 1.5(A) The icosahedral capsid contains 60 identical copies of the protein subunit (blue) labeled A; these are related by fivefold (yellow pentagons at vertices), threefold (yellow triangles in faces), and twofold (yellow ellipses at edges) symmetry elements. For a given-sized subunit, this point group symmetry generates the largest possible assembly (60 subunits) in which every protein lies in an identical environment. (B) Schematic representation of the subunit building block found in many RNA and some DNA viral structures. Such subunits have complementary interfacial surfaces which, when they repeatedly interact, lead to the symmetry of the icosahedron. The tertiary structure of the subunit is an eight-stranded β-barrel with the topology of the jelly-roll. Subunit sizes generally range between 20 and 40 kDa, with variation among different viruses occurring at the N- and C-termini and in the size of insertions between strands of the β-sheet. These insertions generally do not occur at the narrow end of the wedge (B--C, H--I, D--E, and F--G turns). (C) The topology of viral β-barrel, showing the connections between strands of the sheets (represented by yellow or red arrows) and positions of the insertions between strands. The green cylinders represent helices that are usually conserved. The C--D, E--F, and G--H loops often contain large insertions.\[From *Encyclopedia of Virology* (B. W. J. Mahy, M. H. V. van Regenmortel, eds), vol 5, p. 394. Copyright © Academic Press/Elsevier (2008), with permission.\]

The nucleocapsid of several RNA viruses self-assembles as a cylindrical structure in which the protein structural units are arranged as a helix, hence the term *helical symmetry*. It is the shape and repeated occurrence of identical protein--protein interfaces of the structural units that lead to the symmetrical assembly of the helix. In helically symmetrical nucleocapsids, the genomic RNA forms a spiral within the core of the nucleocapsid. The RNA is the organizing element that brings the structural units into correct alignment. Many of the plant viruses with helical nucleocapsids are rod-shaped, flexible, or rigid without an envelope. However, with animal viruses, the helical nucleocapsid is wound into a secondary coil and enclosed within a lipoprotein envelope (e.g., *Rhabdoviridae*) ([Figure 1.6](#f0035){ref-type="fig"} ).Figure 1.6(A) Diagram illustrating a rhabdovirus virion and the nucleocapsid structure (courtesy of P. Le Merder). (B) Negative contrast electron micrograph of particles of an isolate of *Vesicular stomatitis Indiana virus* (courtesy of P. Perrin.). The bar represents 100 nm.\[From *Virus Taxonomy: Eighth Report of the International Committee on Taxonomy of Viruses* (C. M. Fauquet, M. A. Mayo, J. Maniloff, U. Desselberger, L. A. Ball, eds), p. 623. Copyright © Elsevier (2005), with permission.\]

Viral Taxonomy {#s0055}
--------------

With the earliest recognition that infectious agents were associated with a given spectrum of clinical outcomes, it was natural for an agent to take on the name of the disease with which it was associated or the geographic location where it was found, as there was no other basis for assigning a name. Thus the agent that caused foot-and-mouth disease in cattle becomes "foot-and-mouth disease virus," or an agent that caused a febrile disease in the Rift Valley of Africa became "Rift Valley fever virus." It is not difficult at this time in history to see why this *ad hoc* method of naming infectious agents could lead to confusion and regulatory chaos. Different names may be given to the same virus that is both the agent causing a disease in a cow in England and that causing disease in a water buffalo in India. Hog cholera virus existed in North America whereas, in the rest of the world, it was classical swine fever virus, not to be confused with African swine fever virus. Within the same animal, one had infectious bovine rhinotracheitis (IBR) virus and infectious bovine pustular vulvovaginitis (IBPV) virus---both disease entities being caused by bovine herpesvirus 1. Even today, export documents ask for tests to certify animals free of IBR virus *and* IBPV virus. This disease-linked nomenclature could not be changed until such time as the tools became available to define the physical and chemical nature of viruses. With negative-stain electron microscopy as a readily available technology, the size and shape of viruses became a characteristic for defining them. This, along with the ability to define the type of nucleic acid in the virus particle, provided the beginnings of a more rational system of classifying and naming new viruses. Even with a defined shape and a type of nucleic acid, there were still ambiguities in the classification systems that were being developed. Viruses that were transmitted by insect vectors were loosely defined as "*arboviruses*"---arthropod-borne viruses. However, there were viruses that "looked like" arboviruses (togaviruses---viruses with a symmetrical lipid membrane) and had the same nucleic acid, but did not have an insect vector. These became "non-arthropod-borne" togaviruses. Similar ambiguities existed with the group of viruses collectively known as picornaviruses (small RNA viruses). The answer to many of these issues came with the advances in the ability to determine the nucleotide sequences of these agents. Thus the "non-arbo" togaviruses became members of the genera *Rubivirus*, *Pestivirus*, and family *Arteriviridae*.

Even with advances in technologies to characterize individual viruses, there was the need to establish guidelines and procedures for developing a universally acceptable taxonomy for viruses. In 1966, the International Committee on Taxonomy of Viruses (ICTV) was established and charged with establishing, refining, and maintaining a universal virus taxonomy. Given the uncertain origins of viruses, establishing the initial framework for this classification system was not without controversy. Subcommittees and study groups meet periodically to assess new data submitted from the research community to refine the classification system and to place new viruses in their most logical position in the taxonomy scheme. It was not until the Seventh Report of the ICTV (2000) that the concept of virus species as the lowest group in the viral taxa was accepted. The advent of nucleotide sequence determination had a dramatic effect on all biological classification systems, and it has in many respects confirmed the major elements of the classification system. This textbook will use the information presented in the Eighth Report of the ICTV published in 2005. At that time, the ICTV had approved three orders, 73 families, 9 subfamilies, 287 genera, and more than 5000 viruses in 1950 approved species. As the process of classification and defining nomenclature is an ongoing one because of the discovery of new viruses and the generation of sequence data on older isolates, it is impossible for a textbook to be "current." For the most up-to-date information on classification and nomenclature, the reader is directed to the ICTV webpage (<http://www.ictvonline.org/index.asp>).

The hierarchy of recognized viral taxa is: (Order); Family; (Subfamily); Genus; Species. For example, human respiratory syncytial virus A2 would be found in this system as: *Mononegavirales* (order); *Paramyxoviridae* (family); *Pneumovirinae* (subfamily); *Pneumovirus* (genus); *Human respiratory syncytial virus* (species). To be a member of the taxa higher than species, a virus must have all properties defining the classification. In contrast, species are considered a *polythetic class*, in which members have several properties in common but all do not have to share a single defining property. For each genus, there has been designated a *type species*, which is a species that creates a link between the genus and the species. This designation is usually conferred on the species that necessitated the creation of the genus. The published virology literature contains obvious inconsistencies with regard to whether the name of a specific virus is written in italics: *Bovine viral diarrhea virus* versus bovine viral diarrhea virus, for example. In all cases dealing with taxonomy, the order, family, subfamily and genus names should be written in italics and capitalized. In discussing a virus in the context of taxonomy at the species level, the name is written in italics and the first word is capitalized: for example, *Canine distemper virus* is a species in the genus *Morbillivirus*. However, when a virus is written about in terms of tangible properties such as its ability to cause disease, growth in certain cell lines, or its physical characteristics, the name is neither written in italics nor capitalized unless the name contains a proper noun; for example, one can grow canine distemper virus or West Nile virus in monkey cells. There are instances when the abstract (taxonomy) and the concrete aspects of a virus are not clear in the context of the sentence. In this textbook we will attempt to use the ICTV conventions when clearly appropriate, but as this text deals mainly with the tangible aspects of viruses, most virus names will not be in italics.

A basic question that has yet to be addressed is why we should bother with taxonomy at all. For some there seems to be a human need to place things into an ordered system. In characterizing an entity and defining a nomenclature, a basic understanding of the subject under study may be achieved. In a larger context, taxonomy provides a tool for comparing one virus with another or one virus family with another. It also enables one to assign biological properties to a new virus that is provisionally linked to a given family. For instance, if one has an electron micrographic image of a new virus that supports its identity as a coronavirus, then the discoverer can assume they have identified a single-stranded, positive-sense, non-segmented RNA virus. Further, one can extrapolate that coronaviruses are mainly associated with enteric disease, but can also cause respiratory disease in "atypical" hosts after "species jumping." As a group, coronaviruses are difficult to culture *in vitro*, and may require the presence of a protease to enhance growth in tissue culture. Conserved sequences---perhaps in the nucleocapsid---might provide a target for the development of a PCR test. Thus identification of the morphology of an unknown virus can be useful, as the general properties of specific virus families can assist in the interpretation of individual clinical cases. For example, confirming that an alphaherpesvirus was isolated from a particular case confers some basic knowledge about the virus without having explicitly to define the properties of the specific virus. [Table 1.3](#t0020){ref-type="table"} provided some of the basic properties of the animal virus families; [Table 1.4](#t0025){ref-type="table"} lists those discussed in the specific chapters. More detailed properties of the virus families that include significant pathogens of veterinary relevance will be found in specific chapters in Part II of this text.Table 1.4Universal Taxonomy System for Taxa Containing Veterinary and Zoonotic Pathogens[a](#tbl4fna){ref-type="table-fn"}FamilySubfamilyGenusType Species (Host if Not Vertebrate)**DNA VirusesDouble-Stranded DNA Viruses***PoxviridaeChordopoxvirinaeOrthopoxvirus*\
*Capripoxvirus*\
*Leporipoxvirus*\
*Suipoxvirus*\
*Molluscipoxvirus*\
*Avipoxvirus*\
*Yatapoxvirus*\
*Parapoxvirus*\
*Cervidpoxvirus*[a](#tbl4fna){ref-type="table-fn"}*Vaccinia virus*\
*Sheeppox virus*\
*Myxoma virus*\
*Swinepox virus*\
*Molluscum contagiosum virus*\
*Fowlpox virus*\
*Yaba monkey tumor virus*\
*Orf virus*\
*Deerpox virus W-848-83EntomopoxvirinaeEntomopoxvirus*(Insect viruses, but probably also pathogens of fish)*AsfarviridaeAsfivirus*African swine fever virus*IridoviridaeRanavirus*\
*Lymphocystivirus*\
*MegalocytivirusFrog virus 3*\
*Lymphocystis disease virus 1*\
*Infectious spleen and kidney necrosis virusAlloherpesviridaeIctalurivirusIctalurid herpesvirus 1Herpesviridae*\
*AlphaherpesvirinaeSimplexvirus*\
*Varicellovirus*\
*Mardivirus*\
*IltovirusHuman herpesvirus 1*\
*Human herpesvirus 3*\
*Gallid herpesvirus 2*\
*Gallid herpesvirus 1BetaherpesvirinaeCytomegalovirus*\
*Muromegalovirus*\
*Proboscivirus*\
*RoseolovirusHuman herpesvirus 5*\
*Murid herpesvirus 1*\
*Elephantid herpesvirus 1*\
*Human herpesvirus 6GammaherpesvirinaeLymphocryptovirus*\
*Macavirus*\
*Percavirus*\
*RhadinovirusHuman herpesvirus 4*\
*Alcelaphine herpesvirus 1*\
*Equid herpesvirus 2*\
*Saimiriine herpesvirus 2MalacoherpesviridaeOsterovirusOstreid herpesvirus 1AdenoviridaeMastadenovirus*\
*Aviadenovirus*\
*Atadenovirus*\
*SiadenovirusHuman adenovirus C*\
*Fowl adenovirus A*\
*Ovine adenovirus D*\
*Frog adenovirusPolyomaviridaePolyomavirusSimian virus 40PapillomaviridaeAlphapapillomavirus*\
*Betapapillomavirus*\
*Gammapapillomavirus*\
*Deltapapillomavirus*\
*Epsilonpapillomavirus*\
*Zetapapillomavirus*\
*Etapapillomavirus*\
*Thetapapillomavirus*\
*Iotapapillomavirus*\
*Kappapapillomavirus*\
*Lambdapapillomavirus*\
*Mupapillomavirus*\
*Nupapillomavirus*\
*Xipapillomavirus*\
*Omicronpapillomavirus*\
*PipapillomavirusHuman papillomavirus 32*\
*Human papillomavirus 5*\
*Human papillomavirus 4*\
*European elk papillomavirus 1*\
*Bovine papillomavirus 5*\
*Equine papillomavirus 1*\
*Fringilla coelebs papillomavirus*\
*Psittacus erithacus timneh papillomavirus*\
*Mastomys natalensis papillomavirus*\
*Cottontail rabbit papillomavirus*\
*Canine oral papillomavirus*\
*Human papillomavirus 1*\
*Human papillomavirus 41*\
*Bovine papillomavirus 3*\
*Phocoena spinipinnis papillomavirus*\
*Hamster oral papillomavirus***Single-Stranded DNA Viruses***ParvoviridaeParvovirinaeParvovirus*\
*Erythrovirus*\
*Dependovirus*\
*Amdovirus*\
*BocavirusMinute virus of mice*\
*B19 virus*\
*Adeno-associated virus 2*\
*Aleutian mink disease virus*\
*Bovine parvovirusCircoviridaeCircovirus*\
*GyrovirusPorcine circovirus 1*\
*Chicken anemia virus***DNA and RNA Reverse-Transcribing Viruses***HepadnaviridaeOrthohepadnavirus*\
*AvihepadnavirusHepatitis B virus*\
*Duck hepatitis B virusRetroviridae*\
*OrthoretrovirinaeAlpharetrovirus*\
*Betaretrovirus*\
*Gammaretrovirus*\
*Deltaretrovirus*\
*Epsilonretrovirus*\
*LentivirusAvian leukosis virus*\
*Mouse mammary tumor virus*\
*Murine leukemia virus*\
*Bovine leukemia virus*\
*Walleye dermal sarcoma virus*\
*Human immunodeficiency virus 1SpumaretrovirinaeSpumavirusSimian foamy virus***RNA virusesDouble-Stranded RNA Viruses***ReoviridaeOrthoreovirus*\
*Cardoreovirus*\
*Orbivirus*\
*Rotavirus*\
*Seadornavirus*\
*Coltivirus*\
*AquareovirusMammalian orthoreovirus*\
*Eriocheir sinensis reovirus*\
*Bluetongue virus 1*\
*Rotavirus A*\
*Banna virus*\
*Colorado tick fever virus*\
*Aquareovirus ABirnaviridaeAvibirnavirus*\
*AquabirnavirusInfectious bursal disease virus*\
*Infectious pancreatic necrosis virus***Single-Stranded Negative-Sense RNA Viruses***ParamyxoviridaeParamyxovirinaeRespirovirus*\
*Morbillivirus*\
*Rubulavirus*\
*Avulavirus*\
*HenipavirusSendai virus*\
*Measles virus*\
*Mumps virus*\
*Newcastle disease virus*\
*Hendra virusPneumovirinaePneumovirus*\
*MetapneumovirusHuman respiratory syncytial virus*\
*Avian pneumovirusRhabdoviridaeVesiculovirus*\
*Lyssavirus*\
*Ephemerovirus*\
*NovirhabdovirusVesicular stomatitis Indiana virus*\
*Rabies virus*\
*Bovine ephemeral fever virus*\
*Infectious hematopoietic necrosis virusFiloviridaeMarburgvirus*\
*EbolavirusLake Victoria marburgvirus*\
*Zaire ebolavirusBornaviridaeBornavirusBorna disease virusOrthomyxoviridaeInfluenzavirus A*\
*Influenzavirus B*\
*Influenzavirus C*\
*Thogotovirus*\
*IsavirusInfluenza A virus*\
*Influenza B virus*\
*Influenza C virus*\
*Thogoto virus*\
*Infectious salmon anemia virusBunyaviridaeOrthobunyavirus*\
*Hantavirus*\
*Nairovirus*\
*PhlebovirusBunyamwera virus*\
*Hantaan virus*\
*Dugbe virus*\
*Rift Valley fever virusArenaviridaeArenavirusLymphocytic choriomeningitis virus***Single-Stranded Positive-Sense RNA Viruses***CoronaviridaeCoronavirus*\
*TorovirusInfectious bronchitis virus*\
*Equine torovirusArteriviridaeArterivirusEquine arteritis virusRoniviridaeOkavirusGill-associated virusPicornaviridaeEnterovirus*\
*Erbovirus*\
*Hepatovirus*\
*Cardiovirus*\
*Aphthovirus*\
*Parechovirus*\
*Kobuvirus*\
*TeschovirusHuman enterovirus C*\
*Equine rhinitis B virus*\
*Hepatitis A virus*\
*Encephalomyocarditis virus*\
*Foot-and-mouth disease virus*\
*Human parechovirus*\
*Aichi virus*\
*Porcine teschovirusCaliciviridaeVesivirus*\
*Lagovirus*\
*Norovirus*\
*SapovirusVesicular exanthema of swine virus*\
*Rabbit hemorrhagic disease virus*\
*Norwalk virus*\
*Sapporo virusAstroviridaeMamastrovirus*\
*AviastrovirusHuman astrovirus*\
*Turkey astrovirusTogaviridaeAlphavirus*\
*RubivirusSindbis virus*\
*Rubella virusFlaviviridaeFlavivirus*\
*Pestivirus*\
*HepacivirusYellow fever virus*\
*Bovine viral diarrhea virus 1*\
*Hepatitis C virus***Unassigned or Subviral Agents**Unassigned*Hepevirus*\
*Deltavirus*\
*AnellovirusHepatitis E virus*\
*Hepatitis delta virus*\
*Torque teno virus*PrionsScrapie prion[^4]

[^1]: *Some mycoplasmas and chlamydiae are less than 300 nm in diameter and mimiviruses are greater than 300 nm.*

[^2]: *Some viruses contain both types of nucleic acid but, although functional in some cases, are a minor component of the virion.*

[^3]: *dsDNA, double-stranded DNA; dsRNA, double-stranded RNA; kbp, kilobase pairs; NssRNA, negative single-stranded RNA; RT, reverse transcription; ssRNA, single-stranded RNA*.

[^4]: *The terms used reflect the system of the International Committee on Taxonomy of Viruses as at November 2009.*
